Search research articles
Contact Us
Filters
Showing results (191-200 of 372) with videos related to
Page
of 38
Sort By:
Virology Journal
|
July 2, 2024
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG
Lindsay Wieczorek, David Chang, Eric Sanders-Buell, et al.
NPJ Vaccines
|
December 14, 2021
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses
Joshua M Carmen, Shikha Shrivastava, Zhongyan Lu, et al.
Journal of Neuroinflammation
|
February 8, 2022
Neurocognitive impact of Zika virus infection in adult rhesus macaques
Denise C Hsu, Kesara Chumpolkulwong, Michael J Corley, et al.
Vaccine
|
October 9, 2007
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans
Michael A Eller, Leigh Anne Eller, Marc S Opollo, et al.
Plos Pathogens
|
February 6, 2016
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences
Lawrence J Tartaglia, Hui-Wen Chang, Benjamin C Lee, et al.
Biomolecular Detection and Quantification
|
March 30, 2019
Next-generation sequencing of HIV-1 single genome amplicons
Gustavo H Kijak, Eric Sanders-Buell, Phuc Pham, et al.
AIDS Research and Human Retroviruses
|
January 28, 2012
Short communication: Investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007
Paul T Scott, Shilpa Hakre, Otha Myles, et al.
Science Translational Medicine
|
August 30, 2019
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials
Philip K Ehrenberg, Shida Shangguan, Biju Issac, et al.
Ebiomedicine
|
August 20, 2015
Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee
Nathan I Nicely, Kevin Wiehe, Thomas B Kepler, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
M Gordon Joyce, Rajeshwer S Sankhala, Wei-Hung Chen, et al.
Page
of 38
Search research articles
Search
Showing results (191-200 of 372) with videos related to
Sort By:
Page
of 38
Virology Journal
|
July 2, 2024
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG
Lindsay Wieczorek, David Chang, Eric Sanders-Buell, et al.
NPJ Vaccines
|
December 14, 2021
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses
Joshua M Carmen, Shikha Shrivastava, Zhongyan Lu, et al.
Journal of Neuroinflammation
|
February 8, 2022
Neurocognitive impact of Zika virus infection in adult rhesus macaques
Denise C Hsu, Kesara Chumpolkulwong, Michael J Corley, et al.
Vaccine
|
October 9, 2007
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans
Michael A Eller, Leigh Anne Eller, Marc S Opollo, et al.
Plos Pathogens
|
February 6, 2016
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences
Lawrence J Tartaglia, Hui-Wen Chang, Benjamin C Lee, et al.
Biomolecular Detection and Quantification
|
March 30, 2019
Next-generation sequencing of HIV-1 single genome amplicons
Gustavo H Kijak, Eric Sanders-Buell, Phuc Pham, et al.
AIDS Research and Human Retroviruses
|
January 28, 2012
Short communication: Investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007
Paul T Scott, Shilpa Hakre, Otha Myles, et al.
Science Translational Medicine
|
August 30, 2019
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials
Philip K Ehrenberg, Shida Shangguan, Biju Issac, et al.
Ebiomedicine
|
August 20, 2015
Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee
Nathan I Nicely, Kevin Wiehe, Thomas B Kepler, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
M Gordon Joyce, Rajeshwer S Sankhala, Wei-Hung Chen, et al.
Page
of 38